Analysis of how the production and activity of PGD2 affects glioma cell lines.

Detalhes bibliográficos
Autor(a) principal: Ferreira, Matthew Thomas
Data de Publicação: 2015
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Biblioteca Digital de Teses e Dissertações da USP
Texto Completo: http://www.teses.usp.br/teses/disponiveis/42/42134/tde-10042015-120110/
Resumo: The World Health Organization classifies glioblastoma (GBM) as a type IV astrocytoma, making it one of the most fatal tumors that exists. Despite the advances in chemotherapy, surgery, and radiation treatments that improve a patients length of survival, the overall trajectory of the disease remains unchanged. It has been shown that GBM cells produce significant levels of prostaglandins, including prostaglandin D2 (PGD2). PGD2 possesses pro- and anti-tumorigenic properties. Hence, a more complete understanding of PGD2 activity in GBM could yield more effective treatments against GBM. Through techniques like RT-PCR, immunohistochemistry, and HPLC tandem mass spectrometry, we were able to confirm the presence of the PGD2 synthesis in GBM cell lines. We treated GBM cell lines with various concentrations of exogenous PGD2 over 72 hours and observed its effects on cell count, apoptosis, mitosis and viability. Our results suggest that PGD2 possesses contradictory functions in GBM depending on concentration (mM PGD2 vs. nM PGD2) and receptor activation.
id USP_f8d063dd32e98b21067552dd1423c8b6
oai_identifier_str oai:teses.usp.br:tde-10042015-120110
network_acronym_str USP
network_name_str Biblioteca Digital de Teses e Dissertações da USP
repository_id_str 2721
spelling Analysis of how the production and activity of PGD2 affects glioma cell lines.Análise de como a produção e atividade de PGD2 afetam linhagens de glioma.CancerCâncerEicosanoidesEicosanoidsGlioblastomaGlioblastomaOpposing rolesPapeis opostosPGD2PGD2PGE2PGE2ProstaglandinProstaglandinaThe World Health Organization classifies glioblastoma (GBM) as a type IV astrocytoma, making it one of the most fatal tumors that exists. Despite the advances in chemotherapy, surgery, and radiation treatments that improve a patients length of survival, the overall trajectory of the disease remains unchanged. It has been shown that GBM cells produce significant levels of prostaglandins, including prostaglandin D2 (PGD2). PGD2 possesses pro- and anti-tumorigenic properties. Hence, a more complete understanding of PGD2 activity in GBM could yield more effective treatments against GBM. Through techniques like RT-PCR, immunohistochemistry, and HPLC tandem mass spectrometry, we were able to confirm the presence of the PGD2 synthesis in GBM cell lines. We treated GBM cell lines with various concentrations of exogenous PGD2 over 72 hours and observed its effects on cell count, apoptosis, mitosis and viability. Our results suggest that PGD2 possesses contradictory functions in GBM depending on concentration (mM PGD2 vs. nM PGD2) and receptor activation.A Organização Mundial de Saúde classifica glioblastoma (GBM) como um astrocitoma tipo IV, fazendo uns dos tumores mais fatais que existe. A pesar dos avanços em quimioterapia, cirurgia e radioterapia que melhoram a longevidade de sobrevivência, a trajetória geral da doença permanece imutável. Tem sido demonstrado que células de GBM produzem níveis significativos de prostaglandinas, incluindo prostaglandina D2 (PGD2). PGD2 possui propriedades pro- e anti-tumorigenicos. Então, um entendimento mais completo da atividade de PGD2 em GBM pode gerar tratamentos mais efetivos. Através de técnicas como RT-PCR, imunohistoquimicas e HPLC espectrometria de massa em tandem, conseguimos confirmar a presença da síntese de PGD2 em linhagens de GBM. Tratamos linhagens de GBM com concentrações variáveis de PGD2 exógeno durante 72 horas e observamos seus efeitos na contagem de células, apoptose, mitose e viabilidade. Nossos resultados sugerem que PGD2 possui funções opostas em GBM dependendo em concentração (mM PGD2 vs. nM PGD2) e ativação de receptores.Biblioteca Digitais de Teses e Dissertações da USPColquhoun, AlisonFerreira, Matthew Thomas2015-01-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://www.teses.usp.br/teses/disponiveis/42/42134/tde-10042015-120110/reponame:Biblioteca Digital de Teses e Dissertações da USPinstname:Universidade de São Paulo (USP)instacron:USPLiberar o conteúdo para acesso público.info:eu-repo/semantics/openAccesseng2024-08-19T21:15:02Zoai:teses.usp.br:tde-10042015-120110Biblioteca Digital de Teses e Dissertaçõeshttp://www.teses.usp.br/PUBhttp://www.teses.usp.br/cgi-bin/mtd2br.plvirginia@if.usp.br|| atendimento@aguia.usp.br||virginia@if.usp.bropendoar:27212024-08-19T21:15:02Biblioteca Digital de Teses e Dissertações da USP - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Analysis of how the production and activity of PGD2 affects glioma cell lines.
Análise de como a produção e atividade de PGD2 afetam linhagens de glioma.
title Analysis of how the production and activity of PGD2 affects glioma cell lines.
spellingShingle Analysis of how the production and activity of PGD2 affects glioma cell lines.
Ferreira, Matthew Thomas
Cancer
Câncer
Eicosanoides
Eicosanoids
Glioblastoma
Glioblastoma
Opposing roles
Papeis opostos
PGD2
PGD2
PGE2
PGE2
Prostaglandin
Prostaglandina
title_short Analysis of how the production and activity of PGD2 affects glioma cell lines.
title_full Analysis of how the production and activity of PGD2 affects glioma cell lines.
title_fullStr Analysis of how the production and activity of PGD2 affects glioma cell lines.
title_full_unstemmed Analysis of how the production and activity of PGD2 affects glioma cell lines.
title_sort Analysis of how the production and activity of PGD2 affects glioma cell lines.
author Ferreira, Matthew Thomas
author_facet Ferreira, Matthew Thomas
author_role author
dc.contributor.none.fl_str_mv Colquhoun, Alison
dc.contributor.author.fl_str_mv Ferreira, Matthew Thomas
dc.subject.por.fl_str_mv Cancer
Câncer
Eicosanoides
Eicosanoids
Glioblastoma
Glioblastoma
Opposing roles
Papeis opostos
PGD2
PGD2
PGE2
PGE2
Prostaglandin
Prostaglandina
topic Cancer
Câncer
Eicosanoides
Eicosanoids
Glioblastoma
Glioblastoma
Opposing roles
Papeis opostos
PGD2
PGD2
PGE2
PGE2
Prostaglandin
Prostaglandina
description The World Health Organization classifies glioblastoma (GBM) as a type IV astrocytoma, making it one of the most fatal tumors that exists. Despite the advances in chemotherapy, surgery, and radiation treatments that improve a patients length of survival, the overall trajectory of the disease remains unchanged. It has been shown that GBM cells produce significant levels of prostaglandins, including prostaglandin D2 (PGD2). PGD2 possesses pro- and anti-tumorigenic properties. Hence, a more complete understanding of PGD2 activity in GBM could yield more effective treatments against GBM. Through techniques like RT-PCR, immunohistochemistry, and HPLC tandem mass spectrometry, we were able to confirm the presence of the PGD2 synthesis in GBM cell lines. We treated GBM cell lines with various concentrations of exogenous PGD2 over 72 hours and observed its effects on cell count, apoptosis, mitosis and viability. Our results suggest that PGD2 possesses contradictory functions in GBM depending on concentration (mM PGD2 vs. nM PGD2) and receptor activation.
publishDate 2015
dc.date.none.fl_str_mv 2015-01-30
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://www.teses.usp.br/teses/disponiveis/42/42134/tde-10042015-120110/
url http://www.teses.usp.br/teses/disponiveis/42/42134/tde-10042015-120110/
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv
dc.rights.driver.fl_str_mv Liberar o conteúdo para acesso público.
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Liberar o conteúdo para acesso público.
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.coverage.none.fl_str_mv
dc.publisher.none.fl_str_mv Biblioteca Digitais de Teses e Dissertações da USP
publisher.none.fl_str_mv Biblioteca Digitais de Teses e Dissertações da USP
dc.source.none.fl_str_mv
reponame:Biblioteca Digital de Teses e Dissertações da USP
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Biblioteca Digital de Teses e Dissertações da USP
collection Biblioteca Digital de Teses e Dissertações da USP
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações da USP - Universidade de São Paulo (USP)
repository.mail.fl_str_mv virginia@if.usp.br|| atendimento@aguia.usp.br||virginia@if.usp.br
_version_ 1815256907356569600

Registros relacionados